Ovarian aging as a systemic regulator of female healthspan: A call for paradigm shift in geroscience
By
Jennifer L. Garrison
A five-star bake. Worth schmearing, sharing, saving.
Summary
This Perspective article argues that the ovary should be recognized not merely as a reproductive organ but as a systemic regulator of female health and aging. It contends that ovarian aging is a primary determinant of healthspan and belongs at the center of geroscience research. The author calls for a paradigm shift in how scientists and clinicians view the ovary, emphasizing its role in regulating multiple physiological systems beyond reproduction, and highlighting the need for more research into ovarian aging as a key factor in female healthspan.
Key quotes
· 3 pulledClassifying ovaries solely as reproductive organs has obscured their role as systemic regulators of female physiology.
This Perspective discusses that ovarian aging is a primary determinant of healthspan and belongs at the center of geroscience.
Beyond reproduction: The ovary as a systemic regulator of female health and aging
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
